Cancer Incidence and Mortality for Otsego County, 2016-2020

Source: New York State Cancer Registry

Site of Cancer Incidence Mortality
Males and Females Males Females Males and Females Males Females
Average Annual Cases Rate per 100,000 Population 95% CI Average Annual Cases Rate per 100,000 Males 95% CI Average Annual Cases Rate per 100,000 Females 95% CI Average Annual Deaths Rate per 100,000 Population 95% CI Average Annual Deaths Rate per 100,000 Males 95% CI Average Annual Deaths Rate per 100,000 Females 95% CI
All Invasive Malignant Tumors 410.0 481.3 459.1-504.4 209.2 509.6 477.5-543.5 200.8 465.4 434.1-498.5 136.8 150.8 139.1-163.3 69.6 169.0 151.1-188.7 67.2 136.8 121.4-153.8
Oral cavity and pharynx 12.6 14.0 10.6-18.4 8.0 19.3 13.6-26.9 4.6 9.6 5.9-15.4 2.8 2.9 1.6-5.2 2.0 4.4 2.1-8.8 0.8 1.5 0.4-4.8
Esophagus 6.2 6.8 4.5-10.1 5.2 12.4 7.9-19.0 1.0 1.7 0.6-5.1 5.0 5.5 3.4-8.5 4.2 10.2 6.1-16.3 0.8 1.3 0.4-4.6
Stomach 2.8 3.2 1.7-5.8 1.6 4.1 1.6-8.9 1.2 2.3 0.8-5.9 0.8 1.1 0.2-3.3 0.8 2.3 0.5-6.7 0.0 0.0 0.0-3.0
Colorectal 34.4 42.8 36.2-50.4 19.8 53.7 43.0-66.4 14.6 32.7 25.1-42.3 11.8 13.4 10.1-17.7 5.6 13.2 8.7-19.7 6.2 13.4 8.7-20.1
Colon excluding rectum 24.8 30.3 24.9-36.7 13.2 34.9 26.5-45.3 11.6 25.8 19.1-34.3 8.2 9.3 6.6-13.1 3.6 8.5 5.0-14.0 4.6 9.8 5.9-15.6
Rectum & rectosigmoid 9.6 12.5 9.0-17.1 6.6 18.8 12.6-27.2 3.0 6.9 3.6-12.4 3.6 4.1 2.3-6.8 2.0 4.7 2.2-9.3 1.6 3.6 1.4-8.2
Liver / intrahepatic bile duct 4.4 5.1 3.1-8.1 2.4 5.5 2.8-10.2 2.0 4.8 2.2-9.7 3.2 3.9 2.1-6.7 1.8 4.6 2.1-9.3 1.4 3.5 1.2-8.0
Pancreas 12.2 12.9 9.8-16.9 6.0 14.2 9.5-20.8 6.2 12.0 8.0-17.7 10.8 11.2 8.3-14.9 4.8 11.3 7.1-17.5 6.0 11.0 7.4-16.5
Larynx 2.4 2.3 1.2-4.4 2.0 4.2 2.0-8.4 0.4 0.8 0.1-4.0 0.8 0.7 0.2-2.4 0.6 1.4 0.3-5.0 0.2 0.3 0.0-3.3
Lung and bronchus 58.2 62.0 54.8-70.0 28.8 66.4 55.8-78.9 29.4 58.8 49.3-70.0 31.0 33.3 28.1-39.3 17.4 40.2 32.0-50.1 13.6 27.2 20.9-35.2
Melanoma of the skin 22.0 27.6 22.3-34.0 14.0 35.0 27.0-45.0 8.0 22.6 15.3-32.2 2.4 2.5 1.2-4.8 1.2 2.9 1.0-7.2 1.2 2.1 0.7-5.6
Female breast             54.6 136.4 119.0-155.7             6.8 15.2 10.1-22.3
Cervix uteri             2.0 6.2 2.6-12.5             0.8 2.6 0.5-7.3
Corpus uterus and NOS             16.6 39.3 30.4-50.2             2.6 4.6 2.4-8.7
Ovary             4.0 10.2 5.7-16.8             3.6 7.3 4.2-12.3
Prostate       41.2 88.6 76.7-102.2             8.2 19.8 14.2-27.3      
Testis       1.6 7.5 3.2-14.7             0.0 0.0 0.0-2.9      
Urinary bladder (incl. in situ) 23.8 25.3 20.8-30.6 17.4 40.4 32.2-50.4 6.4 13.4 9.0-19.8 4.8 4.8 3.0-7.4 3.4 8.0 4.6-13.3 1.4 2.3 0.9-5.8
Kidney and renal pelvis 14.8 17.3 13.4-22.2 10.6 26.1 19.2-34.8 4.2 10.0 5.9-16.1 3.2 3.4 1.9-5.9 2.2 5.3 2.6-10.0 1.0 2.0 0.7-5.6
Brain and other central nervous system 6.8 8.9 5.9-13.0 3.6 10.4 5.8-17.2 3.2 7.8 4.1-13.7 4.4 5.5 3.3-8.8 2.0 5.6 2.5-10.9 2.4 5.6 2.6-10.7
Thyroid 8.8 15.2 10.6-21.0 3.4 11.9 6.5-19.9 5.4 18.5 11.6-27.9 0.2 0.4 0.0-2.3 0.0 0.0 0.0-2.9 0.2 0.9 0.0-4.6
Hodgkin lymphoma 1.2 1.9 0.6-4.5 0.6 1.8 0.3-6.1 0.6 1.9 0.3-6.3 0.0 0.0 0.0-1.5 0.0 0.0 0.0-2.9 0.0 0.0 0.0-3.0
Non-Hodgkin lymphomas 19.0 22.4 17.8-28.0 11.2 27.3 20.1-36.4 7.8 17.8 12.2-25.4 6.2 6.9 4.5-10.4 3.2 8.3 4.6-14.2 3.0 6.0 3.0-11.1
Myeloma 5.6 6.7 4.3-10.1 4.0 10.3 6.0-16.7 1.6 3.2 1.4-7.1 2.6 2.9 1.5-5.3 1.2 3.1 1.1-7.5 1.4 2.6 1.0-6.2
Leukemias 14.0 15.6 11.9-20.1 8.0 20.0 14.0-28.1 6.0 11.6 7.7-17.4 4.4 5.6 3.4-9.0 2.0 6.6 3.0-12.7 2.4 4.5 2.3-8.6

Notes

  • Incidence data are provisional, November 2022.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.